| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
February 24, 2010 |
|
|
| |
|
|
| |
|
|
|
Drug Information Association, Inc. , Horsham, PA
Mar 15 2010 - Mar 17 2010
All You Need to know about IND Submissions in Only 3 Days Learn how to apply regulatory concepts to ensure compliant IND submissions to FDA. The course focuses on drug and well characterized biological products and not the regulatory process for devices, generic products, or traditional biologics. WHAT YOU WILL LEARN · Overview of the drug development process · The IND process · Quality assurance in drug development (GXPs)· FDA’s actions on the original IND and amendments· Activities and submissions after the original IND· How to interact with FDA · Procedures for reporting adverse events (AEs
|
|
|
|
|
|
|
|
Organized by:
|
|
DIA |
|
|
Invited Speakers:
|
|
Call contact
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
Call contact
|
|
|
|
|
|
|
|
Registration:
|
|
Contact Information:
For detailed program information including faculty and topics, please contact:
Susan Mazak
Tel. +1-215-442-6183
Email Susan.Mazak@diahome.org
|
|
|
E-mail:
|
|
Susan.Mazak@diahome.org
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|